179 related articles for article (PubMed ID: 28298911)
1. Autoantibodies against the
Ehrenreich H
Front Immunol; 2017; 8():181. PubMed ID: 28298911
[TBL] [Abstract][Full Text] [Related]
2. Multiple inducers and novel roles of autoantibodies against the obligatory NMDAR subunit NR1: a translational study from chronic life stress to brain injury.
Pan H; Steixner-Kumar AA; Seelbach A; Deutsch N; Ronnenberg A; Tapken D; von Ahsen N; Mitjans M; Worthmann H; Trippe R; Klein-Schmidt C; Schopf N; Rentzsch K; Begemann M; Wienands J; Stöcker W; Weissenborn K; Hollmann M; Nave KA; Lühder F; Ehrenreich H
Mol Psychiatry; 2021 Jun; 26(6):2471-2482. PubMed ID: 32089545
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease.
Ehrenreich H
Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316
[TBL] [Abstract][Full Text] [Related]
4. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1.
Castillo-Gomez E; Kästner A; Steiner J; Schneider A; Hettling B; Poggi G; Ostehr K; Uhr M; Asif AR; Matzke M; Schmidt U; Pfander V; Hammer C; Schulz TF; Binder L; Stöcker W; Weber F; Ehrenreich H
Ann Neurol; 2016 Jan; 79(1):144-51. PubMed ID: 26505629
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model.
Pan H; Oliveira B; Saher G; Dere E; Tapken D; Mitjans M; Seidel J; Wesolowski J; Wakhloo D; Klein-Schmidt C; Ronnenberg A; Schwabe K; Trippe R; Mätz-Rensing K; Berghoff S; Al-Krinawe Y; Martens H; Begemann M; Stöcker W; Kaup FJ; Mischke R; Boretius S; Nave KA; Krauss JK; Hollmann M; Lühder F; Ehrenreich H
Mol Psychiatry; 2019 Oct; 24(10):1489-1501. PubMed ID: 29426955
[TBL] [Abstract][Full Text] [Related]
6. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke.
Zerche M; Weissenborn K; Ott C; Dere E; Asif AR; Worthmann H; Hassouna I; Rentzsch K; Tryc AB; Dahm L; Steiner J; Binder L; Wiltfang J; Sirén AL; Stöcker W; Ehrenreich H
Stroke; 2015 May; 46(5):1180-6. PubMed ID: 25765725
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against NMDAR subunit NR1 disappear from blood upon anesthesia.
Teller J; Jung C; Wilke JBH; Schimmelpfennig SD; Hindermann M; Hinken L; Gabriel MM; Fegbeutel C; Schäfer A; Laser H; Lichtinghagen R; Worthmann H; Weissenborn K; Ehrenreich H
Brain Behav Immun Health; 2022 Oct; 24():100494. PubMed ID: 35965838
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.
Deutsch NR; Worthmann H; Steixner-Kumar AA; Schuppner R; Grosse GM; Pan H; Gabriel MM; Hasse I; van Gemmeren T; Lichtinghagen R; Ehrenreich H; Weissenborn K
Brain Behav Immun; 2021 Aug; 96():73-79. PubMed ID: 34010714
[TBL] [Abstract][Full Text] [Related]
9. NMDAR1 autoantibodies amplify behavioral phenotypes of genetic white matter inflammation: a mild encephalitis model with neuropsychiatric relevance.
Arinrad S; Wilke JBH; Seelbach A; Doeren J; Hindermann M; Butt UJ; Steixner-Kumar AA; Spieth L; Ronnenberg A; Pan H; Berghoff SA; Hollmann M; Lühder F; Nave KA; Bechter K; Ehrenreich H
Mol Psychiatry; 2022 Dec; 27(12):4974-4983. PubMed ID: 34866134
[TBL] [Abstract][Full Text] [Related]
10. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class.
Castillo-Gómez E; Oliveira B; Tapken D; Bertrand S; Klein-Schmidt C; Pan H; Zafeiriou P; Steiner J; Jurek B; Trippe R; Prüss H; Zimmermann WH; Bertrand D; Ehrenreich H; Hollmann M
Mol Psychiatry; 2017 Dec; 22(12):1776-1784. PubMed ID: 27502473
[TBL] [Abstract][Full Text] [Related]
11. Factors predisposing to humoral autoimmunity against brain-antigens in health and disease: Analysis of 49 autoantibodies in over 7000 subjects.
Daguano Gastaldi V; Bh Wilke J; Weidinger CA; Walter C; Barnkothe N; Teegen B; Luessi F; Stöcker W; Lühder F; Begemann M; Zipp F; Nave KA; Ehrenreich H
Brain Behav Immun; 2023 Feb; 108():135-147. PubMed ID: 36323361
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of autoantibodies against brain antigens in health and disease.
Dahm L; Ott C; Steiner J; Stepniak B; Teegen B; Saschenbrecker S; Hammer C; Borowski K; Begemann M; Lemke S; Rentzsch K; Probst C; Martens H; Wienands J; Spalletta G; Weissenborn K; Stöcker W; Ehrenreich H
Ann Neurol; 2014 Jul; 76(1):82-94. PubMed ID: 24853231
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis.
Wilke JBH; Hindermann M; Berghoff SA; Zihsler S; Arinrad S; Ronnenberg A; Barnkothe N; Steixner-Kumar AA; Röglin S; Stöcker W; Hollmann M; Nave KA; Lühder F; Ehrenreich H
Mol Psychiatry; 2021 Dec; 26(12):7746-7759. PubMed ID: 34331009
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.
Hammer C; Stepniak B; Schneider A; Papiol S; Tantra M; Begemann M; Sirén AL; Pardo LA; Sperling S; Mohd Jofrry S; Gurvich A; Jensen N; Ostmeier K; Lühder F; Probst C; Martens H; Gillis M; Saher G; Assogna F; Spalletta G; Stöcker W; Schulz TF; Nave KA; Ehrenreich H
Mol Psychiatry; 2014 Oct; 19(10):1143-9. PubMed ID: 23999527
[TBL] [Abstract][Full Text] [Related]
15. Serum Anti-NMDA (N-Methyl-D-Aspartate)-Receptor Antibodies and Long-Term Clinical Outcome After Stroke (PROSCIS-B).
Sperber PS; Siegerink B; Huo S; Rohmann JL; Piper SK; Prüss H; Heuschmann PU; Endres M; Liman TG
Stroke; 2019 Nov; 50(11):3213-3219. PubMed ID: 31526121
[TBL] [Abstract][Full Text] [Related]
16. Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
Kreye J; Wenke NK; Chayka M; Leubner J; Murugan R; Maier N; Jurek B; Ly LT; Brandl D; Rost BR; Stumpf A; Schulz P; Radbruch H; Hauser AE; Pache F; Meisel A; Harms L; Paul F; Dirnagl U; Garner C; Schmitz D; Wardemann H; Prüss H
Brain; 2016 Oct; 139(Pt 10):2641-2652. PubMed ID: 27543972
[TBL] [Abstract][Full Text] [Related]
17. Acute psychosis due to non-paraneoplastic anti-NMDA-receptor encephalitis in a teenage girl: Case report.
Kramina S; Kevere L; Bezborodovs N; Purvina S; Rozentals G; Strautmanis J; Viksna Z
Psych J; 2015 Dec; 4(4):226-30. PubMed ID: 26663628
[TBL] [Abstract][Full Text] [Related]
18. Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium.
Punja M; Pomerleau AC; Devlin JJ; Morgan BW; Schier JG; Schwartz MD
Clin Toxicol (Phila); 2013; 51(8):794-7. PubMed ID: 23962100
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis.
Malter MP; Elger CE; Surges R
Seizure; 2013 Mar; 22(2):136-40. PubMed ID: 23318046
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic injection of cerebrospinal fluid from anti-NMDA receptor encephalitis into rat dentate gyrus impairs NMDA receptor function.
Würdemann T; Kersten M; Tokay T; Guli X; Kober M; Rohde M; Porath K; Sellmann T; Bien CG; Köhling R; Kirschstein T
Brain Res; 2016 Feb; 1633():10-18. PubMed ID: 26721688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
